108 related articles for article (PubMed ID: 27258774)
21. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Hallar M; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Transpl Immunol; 2008 Nov; 20(1-2):61-7. PubMed ID: 18929659
[TBL] [Abstract][Full Text] [Related]
22. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
[TBL] [Abstract][Full Text] [Related]
23. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
24. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
25. For anti-HLA-specific donor antibodies detection by flow cytometry cytotoxic crossmatches comparison of methods.
Cervelli C; Pisani F; Aureli A; Azzarone R; Scimitarra M; Battistoni C; Di Iulio B; Fracassi D; Scarnecchia MA; Famulari A; Papola F
Transplant Proc; 2013 Sep; 45(7):2761-4. PubMed ID: 24034042
[TBL] [Abstract][Full Text] [Related]
26. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
Abdel Rahman AS; Fahim NM; El Sayed AA; El Hady SA; Ahmad YS
Egypt J Immunol; 2005; 12(2):77-89. PubMed ID: 17977213
[TBL] [Abstract][Full Text] [Related]
27. Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens.
Reinsmoen NL; Patel J; Mirocha J; Lai CH; Naim M; Ong G; Wang Q; Zhang X; Liou F; Yu Z; Kobashigawa J
J Heart Lung Transplant; 2016 Feb; 35(2):165-72. PubMed ID: 26683810
[TBL] [Abstract][Full Text] [Related]
28. [Indications for apheresis in kidney transplant recipients: apheresis in the hyperimmune patient].
Busnach G; Di Leo L
G Ital Nefrol; 2012; 29 Suppl 54():S22-6. PubMed ID: 22388825
[TBL] [Abstract][Full Text] [Related]
29. Solid phase-based cross-matching as solution for kidney allograft recipients pretreated with therapeutic antibodies.
Schlaf G; Apel S; Wahle A; Altermann WW
Biomed Res Int; 2015; 2015():587158. PubMed ID: 25654115
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength.
Ellis TM; Schiller JJ; Roza AM; Cronin DC; Shames BD; Johnson CP
Hum Immunol; 2012 Jul; 73(7):706-10. PubMed ID: 22537747
[TBL] [Abstract][Full Text] [Related]
31. The crossmatch in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity.
Scornik JC; Brunson ME; Schaub B; Howard RJ; Pfaff WW
Transplantation; 1994 Feb; 57(4):621-5. PubMed ID: 8116050
[TBL] [Abstract][Full Text] [Related]
32. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.
Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC
Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107
[TBL] [Abstract][Full Text] [Related]
33. The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation.
Nguyen HT; Lim WH; Craig JC; Chapman JR; Lord SJ; Howard K; Wong G
Transplantation; 2015 May; 99(5):957-64. PubMed ID: 25943234
[TBL] [Abstract][Full Text] [Related]
34. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
35. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody.
Higgins R; Hathaway M; Lowe D; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Zehnder D; Chen K; Krishnan N; Hamer R; Briggs D
Transplantation; 2007 Oct; 84(7):876-84. PubMed ID: 17984841
[TBL] [Abstract][Full Text] [Related]
36. Transnational validation of the Australian algorithm for virtual crossmatch allocation in kidney paired donation.
Böhmig GA; Fidler S; Christiansen FT; Fischer G; Ferrari P
Hum Immunol; 2013 May; 74(5):500-5. PubMed ID: 23380140
[TBL] [Abstract][Full Text] [Related]
37. Highly Sensitized Patients: Miami Transplant Institute Experience.
Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
[TBL] [Abstract][Full Text] [Related]
38. Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance.
Svobodova E; Gazdic T; Kubanek M; Vymetalova J; Voska L; Kment M; Lanska V; Kolesar L; Urban M; Netuka I; Pirk J; Melenovsky V; Kautzner J; Slavcev A; Malek I
Transpl Int; 2016 Jan; 29(1):63-72. PubMed ID: 26340387
[TBL] [Abstract][Full Text] [Related]
39. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
[TBL] [Abstract][Full Text] [Related]
40. New crossmatch technique eliminates interference by humanized and chimeric monoclonal antibodies.
Book BK; Agarwal A; Milgrom AB; Bearden CM; Sidner RA; Higgins NG; Pescovitz MD
Transplant Proc; 2005 Mar; 37(2):640-2. PubMed ID: 15848485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
